Predicting the Toxicity of Weekly Docetaxel in Advanced Cancer

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.45, Iss.6, 2006-01, pp. : 611-622

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docetaxel response, toxicity related to dose in breast cancer

Inpharma, Vol. 1, Iss. 1562, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Weekly topotecan plus paclitaxel induces promising response rates with very low toxicity in advanced non-small-cell lung cancer

Inpharma, Vol. 1, Iss. 1553, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Advanced breast cancer - a NICE result for docetaxel

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 270, 2000-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Trastuzumab/docetaxel/platinum salts for advanced breast cancer

Inpharma, Vol. 1, Iss. 1442, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Advanced breast cancer - a NICE result for docetaxel

Inpharma, Vol. 1, Iss. 1246, 2000-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite